Showing results (11-20 of 155) with videos related to
Sort By:
Pageof 16
Cancer Treatment Reviews|July 27, 2012
What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?Emiliano Calvo, Alain Ravaud, Joaquim BellmuntOncotargets and Therapy|July 10, 2010
Multiple roles and therapeutic implications of Akt signaling in cancerEmiliano Calvo, Victoria Bolós, Enrique GrandeEuropean Journal of Cancer (Oxford, England : 1990)|March 6, 2014
Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapyEmiliano Calvo, Viktor Grünwald, Joaquim BellmuntMolecular Cancer Therapeutics|January 4, 2018
Rational Approaches for Combination Therapy Strategies Targeting the MAP Kinase Pathway in Solid TumorsAnthony W Tolcher, Wei Peng, Emiliano CalvoThe Oncologist|August 31, 2018
The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell CarcinomaEmiliano Calvo, Camillio Porta, Viktor Grünwald, et al.Cancer|June 1, 2026
Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directionsAndré Mansinho, Joana Albuquerque, Andreia Lopes, et al.The Lancet Regional Health. Europe|May 8, 2026
Antibody-drug conjugates in cancer treatment: from molecular design to clinical implementationAndré Mansinho, Joana Albuquerque, Chiara Barigazzi, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted TherapiesEmiliano Calvo, Christine Walko, E Claire Dees, et al.Current Opinion in Oncology|July 6, 2017
Immunotherapy-based combinations: current status and perspectivesMaría J de Miguel-Luken, André Mansinho, Valentina Boni, et al.Current Opinion in Pharmacology|June 21, 2021
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyondVictor Moreno, Tatiana Hernandez, Maria de Miguel, et al.Pageof 16